“There are still many unknowns about what the presence of SARS-CoV-2 antibodies may tell us about potential immunity,” Dr. Tim Stenzel, director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health said in a July statement, when the FDA approved earlier tests that measured antibody levels in general. “Patients should not interpret results as telling them they are immune, or have any level of immunity, from the virus.”
Prepare Now Before its too Late
Discover where products are available & compare prices
